Cargando…
Multi-regional clinical trials and global drug development
Drug development has been globalized, and multi-regional clinical trial (MRCT) for regulatory submission has widely been conducted by many discovery based global pharmaceutical companies with the objective of reducing the time lag of launch in key markets and improve patient access to new and innova...
Autor principal: | Shenoy, Premnath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840793/ https://www.ncbi.nlm.nih.gov/pubmed/27141471 http://dx.doi.org/10.4103/2229-3485.179430 |
Ejemplares similares
-
Elderly patients’ participation in clinical trials
por: Shenoy, Premnath, et al.
Publicado: (2015) -
Electronic informed consenting: A boon to modernize consenting process
por: Shenoy, Premnath
Publicado: (2015) -
Regional clinical pharmacology trials for Multi-Regional clinical trials
por: Jang, In-Jin
Publicado: (2018) -
COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective
por: Nishiwaki, Satoshi, et al.
Publicado: (2021) -
Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
por: Asano, Kunihito, et al.
Publicado: (2017)